A comprehensive SARS-CoV-2 genomic analysis identifies potential targets for drug repurposing. Anand NM, Liya DH, Pradhan AK, Tayal N, et al. PLoS One 2021;16:e0248553.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Anand NM, Liya DH, Pradhan AK, Tayal N, et al. A comprehensive SARS-CoV-2 genomic analysis identifies potential targets for drug repurposing. PLoS One 2021;16:e0248553.
PMID: 33735271